John D. Morrey
Institute for Antiviral Research
Department of Animal
Dairy
and Veterinary Sciences
USA
Name/email consistency: high
- Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. Morrey, J.D., Olsen, A.L., Siddharthan, V., Motter, N.E., Wang, H., Taro, B.S., Chen, D., Ruffner, D., Hall, J.O. J. Gen. Virol. (2008)
- Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model. Morrey, J.D., Siddharthan, V., Olsen, A.L., Wang, H., Julander, J.G., Hall, J.O., Li, H., Nordstrom, J.L., Koenig, S., Johnson, S., Diamond, M.S. Antimicrob. Agents Chemother. (2007)
- Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. Morrey, J.D., Siddharthan, V., Olsen, A.L., Roper, G.Y., Wang, H., Baldwin, T.J., Koenig, S., Johnson, S., Nordstrom, J.L., Diamond, M.S. J. Infect. Dis. (2006)
- Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Morrey, J.D., Day, C.W., Julander, J.G., Blatt, L.M., Smee, D.F., Sidwell, R.W. Antivir. Chem. Chemother. (2004)
- Modeling hamsters for evaluating West Nile virus therapies. Morrey, J.D., Day, C.W., Julander, J.G., Olsen, A.L., Sidwell, R.W., Cheney, C.D., Blatt, L.M. Antiviral Res. (2004)
- Identification of active antiviral compounds against a New York isolate of West Nile virus. Morrey, J.D., Smee, D.F., Sidwell, R.W., Tseng, C. Antiviral Res. (2002)
- Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Morrey, J.D., Bailey, K.W., Korba, B.E., Sidwell, R.W. Antiviral Res. (1999)
- Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Morrey, J.D., Korba, B.E., Sidwell, R.W. Antivir. Ther. (Lond.) (1998)